Menu Close

Gastric Cancer

  • Epidemiology
    • Gender: More common in men
    • Age: 40 to 70 years
  • Pathophysiology
    • Adenocarcinoma accounts for 95% of cases
    • Atrophic Gastritis precedes metaplasia and malignancy
  • Risk Factors
    • Familial Adenomatous Polyposis
    • Non-polyposis hereditary Colon Cancer
    • Gastric adenoma
    • Barrett’s Esophagus (cardiac and esophageal border)
    • Tobacco Abuse
    • Chronic atrophic Gastritis
    • positive family history in 4% of cases
    • diseases that produce hypochlorhydric or achlorhydric states
      • 🡪 encourage bacterial colonization and conversion of dietary nitrates and nitrites into nitrosamines:
      • pernicious anaemia
      • chronic gastritis
        • Helicobacter pylori
      • Pernicious Anemia 
      • Prior subtotal gastrectomy (after 15-20 years) – risk of malignancy in residual stump is increased 2-6 fold
    • increased incidence in certain ethnic and racial groups
      • blacks, American Indians, Maori’s, Japanese
    • Environmental
      • Tobacco smoking, obesity, occupations involving rubber production and exposure to X-radiation or gamma radiation
  • Symptoms
    • Asymptomatic in early stages in 80% of cases
    • Late stage symptoms
      • Weight loss
      • Nausea and Vomiting
      • Abdominal Pain
      • Early satiety
  • Signs
    • Palpable epigastric mass
    • Hepatomegaly
    • Lymphadenopathy (e.g. periumbilical or supraclavicular)
  • Differential Diagnosis
    • Peptic Ulcer Disease
    • Gastroesophageal Reflux disease
  • Diagnostic Testing
    • Upper endoscopy (Esophogastroduodenoscopy or EGD)
    • Endoscopic Ultrasonography (EUS)
  • Prognosis: Five year survival
    • Stages (Summary of AJCC Staging – not an exact list)
    • Stage 0: Tis, N0, M0 (Carcinoma in-situ) 90%
    • Stage I: T1, N0, M0 (Submucosa involved) <78%
    • Stage II: T1-T3, N0-N2, M0 (visceral peritoneum) 34%
    • Stage III: T2a-T4, N0-N2, M0 (local tumor invasion) <20%
    • Stage IV: T1-T4, N1-N3, M0-1 (increased metastases) 7%
  • Prevention
    • Tobacco Cessation
    • Dietary changes (possible benefit)
      • Decrease Alcohol intake
      • Decrease smoked, pickled or salted food intake
      • Increase fruit and vegetable intake
    • Aggressively treat and monitor associated conditions
      • Barrett’s Esophagus
      • Atrophic Gastritis
      • Helicobacter Pylori infection
    • Screening EGD for high risk patients every 1-3 years

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.